Once daily initiation with biphasic insulin aspart 30 (BIAsp 30) versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs - a randomized controlled trial

被引：0
|
作者：
Franek, E. [1 ]
Kalra, S. [2 ]
Pesic, M. [3 ]
Smahelova, A. [4 ]
Thomsen, H. [5 ]
Strojek, K. [6 ]
机构：
[1] Cent Szpital Klin MSWIA, Warsaw, Poland
[2] Bharti Hosp, Karnal, India
[3] Clin Ctr Nis, Nish, Serbia
[4] Fak Hosp, Hradec Kralove, Czech Republic
[5] Novo Nordisk AS, Aalborg, Denmark
[6] Dept Internal Dis Diabetol & Nephrol, Zabrze, Poland
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
213
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] Once-Daily Initiation with NovoMix® 30 (BIAsp 30) vs Insulin Glargine in Patients with Type 2 Diabetes Inadequately Controlled with Oral Drugs: A Randomized Controlled Trial
    Strojek, Krzysztof
    Bebakar, Wan M. W.
    Khutsoane, Duma T.
    Pesic, Milica
    Smahelova, Alena
    Thomsen, Henrik F.
    Kalra, Sanjay
    [J]. DIABETES, 2009, 58 : A146 - A146
  • [2] Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
    Strojek, Krzysztof
    Bebakar, Wan M. W.
    Khutsoane, Duma T.
    Pesic, Milica
    Smahelova, Alena
    Thomsen, Henrik F.
    Kalra, Sanjay
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2887 - 2894
  • [3] Initiation with once-daily BIAsp 30 results in superior outcome compared to insulin glargine in Asians with type 2 diabetes inadequately controlled by oral anti-diabetic drugs
    Kalra, Sanjay
    Plata-Que, Teresa
    Kumar, Dileep
    Mumtaz, Malik
    Sondergaard, Flemming
    Kozlovski, Plamen
    Bebakar, Wan Mohamad Wan
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 88 (03) : 282 - 288
  • [4] Superior glycaemic control with once-daily insulin degludec/insulin aspart versus insulin glargine in Japanese adults with type 2 diabetes inadequately controlled with oral drugs: a randomized, controlled phase 3 trial
    Onishi, Y.
    Ono, Y.
    Rabol, R.
    Endahl, L.
    Nakamura, S.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (09): : 826 - 832
  • [5] Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial
    Onishi, Yukiko
    Yamada, Kenichi
    Zacho, Jeppe
    Ekelund, Jan
    Iwamoto, Yasuhiko
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (02) : 210 - 217
  • [6] Comparison of twice-daily biphasic insulin aspart 70/30 (BIAsp 70/30) with once-daily insulin glargine (GLA) in patients with type 2 DM on oral antidiabetic agents
    Raskin, P
    Rojas, P
    Allen, E
    [J]. DIABETES, 2004, 53 : A143 - A143
  • [7] A COMPARISON OF TWICE-DAILY BIPHASIC INSULIN ASPART 70/30 AND ONCE-DAILY INSULIN GLARGINE IN PERSONS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON BASAL INSULIN AND ORAL THERAPY: A RANDOMIZED, OPEN-LABEL STUDY
    Ligthelm, Robert J.
    Gylvin, Titus
    DeLuzio, Tony
    Raskin, Philip
    [J]. ENDOCRINE PRACTICE, 2011, 17 (01) : 41 - 50
  • [8] Insulin Degludec/Insulin Aspart (IDegAsp) Twice Daily (BID) vs. Biphasic Insulin Aspart 30 (BIAsp 30) BID-A Randomized Trial in Chinese Patients with Type 2 Diabetes
    Yang, Wenying
    Ma, Jianhua
    Hong, Tianpei
    Liu, Ming
    Miao, Heng
    Peng, Yongde
    Wang, Changjiang
    Xu, Xiangjin
    Yang, Tao
    Nielsen, Anne Moeller
    Pan, Lili
    Liu, Weihong
    Zhao Weigang
    [J]. DIABETES, 2018, 67
  • [9] Insulin degludec/insulin aspart (IDegAsp) twice daily (BID) vs biphasic insulin aspart 30 (BIAsp 30) BID: a randomised trial in Chinese patients with type 2 diabetes
    Ma, J.
    Yang, W.
    Hong, T.
    Liu, M.
    Miao, H.
    Peng, Y.
    Wang, C.
    Xu, X.
    Yang, T.
    Liu, W.
    Nielsen, A. Moeller
    Pan, L.
    Weigang, Z.
    [J]. DIABETOLOGIA, 2018, 61 : S410 - S411
  • [10] Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs
    Yang, Wenying
    Ersoy, Canan
    Wang, Guixia
    Ye, Shandong
    Liu, Jun
    Miao, Heng
    Asirvatham, Arthur
    Werther, Shanti
    Kadu, Priti
    Chow, Francis
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 150 : 158 - 166
12345